AVEO Oncology, an LG Chem company

Boston,  MA 
United States
http://www.aveooncology.com

• Booth: 18025a

AVEO Oncology (AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need. AVEO’s strategy is to focus its resources toward the development and commercialization of its product candidates in North America, while leveraging partnerships to do the same in other geographies. In March 2021, AVEO received FDA approval of FOTIVDA® (tivozanib). To learn more about FOTIVDA efficacy, safety, and relevant resources, visit our website at FOTIVDAHCP.com or click the link below.

Brands: https://events.jspargo.com/ASCO21/CUSTOM/AVEO%20Banner.png

 Press Releases

• 2) FOTIVDA.com (Apr 21, 2021)
  www.fotivda.com

• 6) Prescribing Information (Apr 21, 2021)
  https://www.fotivdahcp.com/fotivdapi.pdf

• 4) FOTIVDA Patient Experience Program (Apr 21, 2021)
  https://www.fotivdahcp.com/patient-experience-program/

• 3) AVEO Access Center of Excellence: Comprehensive Personalized Patient Support (Apr 21, 2021)
  https://www.fotivdahcp.com/access-support/aveo-ace/

• 5) Resources to Help with the Treatment Journey (Apr 21, 2021)
  https://www.fotivdahcp.com/resources/

• 1) "Drop a Business Card" to help AVEO donate to cancer patient advocacy foundation (Apr 30, 2021)

  https://events.jspargo.com/ASCO21/CUSTOM/AVEO%20asco%20fundraising.pdf

 Products